{
    "title": "Eli Lilly: Experimental Alzheimer's drug shows some benefit",
    "url": "https://www.dailymail.co.uk/wires/ap/article-3170853/Eli-Lilly-Experimental-Alzheimers-drug-shows-benefit.html",
    "date": "2015-07-22",
    "keywords": [
        "study",
        "drug",
        "latestage",
        "dr",
        "benefit",
        "gmt",
        "july",
        "protein",
        "time",
        "decline",
        "group",
        "researcher",
        "university",
        "gantenerumab",
        "press",
        "email",
        "washington",
        "co",
        "wednesday",
        "medication",
        "mild",
        "handful",
        "testing",
        "frustrating",
        "hunt",
        "lillys",
        "end",
        "conference",
        "research",
        "effort",
        "brainthe",
        "bottom",
        "line",
        "approach",
        "target",
        "tomorrow",
        "foundation",
        "david",
        "knopman",
        "mayo",
        "clinic",
        "look",
        "candidate",
        "signal",
        "disease",
        "subset",
        "milder",
        "everyone",
        "placebothe",
        "solanezumab",
        "beginning",
        "difference",
        "test",
        "paul",
        "aisen",
        "californiagantenerumabroche",
        "december",
        "goal",
        "closer",
        "analysis",
        "amyloid",
        "tau",
        "lead",
        "philip",
        "vu",
        "center",
        "amsterdamgantenerumab",
        "lasseraducanumabbiogen",
        "firststage",
        "aducanumab",
        "spring",
        "dose",
        "side",
        "effect",
        "brain",
        "fluid",
        "buildup",
        "director",
        "jeff"
    ],
    "category": [
        "wires",
        "ap"
    ]
}